# Home Use Sensor Study

> **NCT02932514** · NA · UNKNOWN · sponsor: **Senseonics, Inc.** · enrollment: 17 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** Eversense (Senseonics) Continuous Glucose Monitoring System

## Key facts

- **NCT ID:** NCT02932514
- **Lead sponsor:** Senseonics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2017-07
- **Final completion:** —
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02932514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02932514, "Home Use Sensor Study". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02932514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*